Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lucy Hampson
Observed institutions:
University of Dundee,
King's College London,
Medical Research Council
OpenAlex ID:
A5085642995
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
2023
·
Jesse J Swen
, Cathelijne H van der Wouden
, et al.
·
The Lancet
·
557
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
Show more works
View as search
Works count:
6
Citation count:
2,161
H-index:
6
I10-index:
6
Year
Topic
Type
